Multimodal imaging for improved diagnosis and treatment of cancers
Open Access
Abstract
The authors review methods for image‐guided diagnosis and therapy that increase precision in the detection, characterization, and localization of many forms of cancer to achieve optimal target definition and complete resection or ablation. A new model of translational, clinical, image‐guided therapy research is presented, and the Advanced Multimodality Image‐Guided Operating (AMIGO) suite is described. AMIGO was conceived and designed to allow for the full integration of imaging in cancer diagnosis and treatment. Examples are drawn from over 500 procedures performed on brain, neck, spine, thorax (breast, lung), and pelvis (prostate and gynecologic) areas and are used to describe how they address some of the many challenges of treating brain, prostate, and lung tumors. Cancer 2015;121:817–827. © 2014 American Cancer Society.Keywords
Funding Information
- NIH/Bioengineering Research Partnership (R01 CA111288)
- NIH/NCI (R01 CA160902-01A1)
- NIH/NCRR, NIBIB (P41 RR019703)
- NIH/NIBIB (P41 EB015898)
- Siemens
This publication has 50 references indexed in Scilit:
- A Bayesian nonrigid registration method to enhance intraoperative target definition in image‐guided prostate procedures through uncertainty characterizationMedical Physics, 2012
- In-bore setup and software for 3T MRI-guided transperineal prostate biopsyPhysics in Medicine & Biology, 2012
- ESUR prostate MR guidelines 2012European Radiology, 2012
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Development of Stereotactic Mass Spectrometry for Brain Tumor SurgeryNeurosurgery, 2011
- Prostate Tumor Volume Measurement with Combined T2-weighted Imaging and Diffusion-weighted MR: Correlation with Pathologic Tumor VolumeRadiology, 2009
- Survival of Patients with Stage I Lung Cancer Detected on CT ScreeningNew England Journal of Medicine, 2006
- Supratentorial Low-Grade Glioma Resectability: Statistical Predictive Analysis Based on Anatomic MR Features and Tumor CharacteristicsRadiology, 2006
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- Survival rates in patients with low‐grade glioma after intraoperative magnetic resonance image guidanceCancer, 2005